Value of Medicines
Who We Are
Our Industry
Resources
COVID-19
Member Login
Resources
Submissions
See all
Submission to the Health Select Committee on the Medicines Amendment Bill (No 2)
Submission to the Foreign Affairs, Defence and Trade Committee on the International treaty examination of the UK-NZ Free Trade Agreement
Submission to the Education and Workforce Committee on the Accident Compensation (Maternal Birth Injury and Other Matters) Amendment Bill
Medsafe Consultation: Proposed Revisions to CMN Form A
Submission to the Pae Ora Legislation Committee on the Pae Ora (Healthy Futures) Bill
PHARMAC Consultation: Proposal (dated 29 June 2021) to decline inactive funding applications
Medsafe Consultation: Medsafe Fees Review
PHARMAC Consultation: Revised Terms of Reference for CAC, PTAC and PTAC Sub-Committees and Associated PHARMAC Discussions document
Publications
See all
New Zealand's Medicines Landscape 2021/22
Whitepaper: Impact of Living with a Rare Disorder in Aotearoa New Zealand
Key Findings of a National Omnibus Survey - Perceptive January 2022
IQVIA Access to Medicines (AtoM 3) Report 2011-2020
IQVIA A Decade of Modern Medicines: An International Comparison 2011 – 2020
Educational Whitepaper: Towards Best Practice in Consumer Involvement in Decisions about Funding Medicines in New Zealand
New Zealand's Medicines Landscape 2020/21
Public Perceptions of Healthcare, Pharmaceuticals and COVID-19 in New Zealand Key Findings of two National Online Surveys April 2021
Media Releases
See all
PHARMAC Review: A step in the right direction, but 'devil will be in the detail' for Government on actions to be taken
Budget 2022 Medicines Investment: A start, but also a potential rapid and painful stop?
Medicines Sector Actively Responds to the Ukraine Crisis in Europe
Trans-Tasman Medicines Report: New Zealand Appalling Inequity Gap Exposed
International Medicines Report: New Zealand Past the Point of No Return?
Boring Budget 2021 reinforces two tier medicines access system in New Zealand
Medicines New Zealand supportive of Government’s PHARMAC Review assuming it is not a box-ticking exercise
Medicines New Zealand and the New Zealand Medical Association launch Transparency Initiative
